{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:33:33Z","timestamp":1787312013499,"version":"build-2736575974"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073441"],"award-info":[{"award-number":["82073441"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tsqn201909141"],"award-info":[{"award-number":["tsqn201909141"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jad.2024.08.077","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T02:20:01Z","timestamp":1723688401000},"page":"112-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Efficacy and safety of drugs for psoriasis patients with mental disorders: A systematic review"],"prefix":"10.1016","volume":"365","author":[{"given":"Meng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2024.08.077_bb0005","first-page":"128","article-title":"Evidence for anti-inflammatory effects of adalimumab in treatment of patients with major depressive disorder: a pilot, randomized, controlled trial","volume":"45","author":"Abbasian","year":"2022","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jad.2024.08.077_bb0010","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1176\/appi.ajp.160.7.1355","article-title":"Lithium-associated psoriasis and Omega-3 fatty acids","volume":"160","author":"Akkerhuis","year":"2003","journal-title":"AJP"},{"key":"10.1016\/j.jad.2024.08.077_bb0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0190-9622(98)70240-3","article-title":"Is the efficacy of topical corticosteroid therapy for psoriasis vulgaris enhanced by concurrent moclobemide therapy?","volume":"38","author":"Alpsoy","year":"1998","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0020","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/1346-8138.16917","article-title":"Effects of brodalumab on psoriasis and depressive symptoms in patients with insufficient response to TNF-\u03b1 inhibitors","volume":"50","author":"Andersch-Bj\u00f6rkman","year":"2023","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0025","doi-asserted-by":"crossref","unstructured":"Atigari, O.V., Healy, D., 2014. Schizophrenia-like disorder associated with etanercept treatment. Case reports 2014, bcr2013200464\u2013bcr2013200464. https:\/\/doi.org\/10.1136\/bcr-2013-200464.","DOI":"10.1136\/bcr-2013-200464"},{"key":"10.1016\/j.jad.2024.08.077_bb0030","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jamadermatol.2020.3617","article-title":"Effect of Risankizumab on patient-reported outcomes in moderate to severe psoriasis: the UltIMMa-1 and UltIMMa-2 randomized clinical trials","volume":"156","author":"Augustin","year":"2020","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2474-14-13","article-title":"Improved health outcomes with Etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis","volume":"14","author":"Bae","year":"2013","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.jad.2024.08.077_bb0040","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0033-3182(76)71133-2","article-title":"More about the relationship of Lithium to psoriasis","volume":"17","author":"Bakker","year":"1976","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jad.2024.08.077_bb0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.crohns.2008.10.003","article-title":"Perception of improved state of health and subjective quality of life in Crohn\u2019s disease patients treated with infliximab","volume":"3","author":"Banovic","year":"2009","journal-title":"J. Crohn\u2019s Colitis"},{"key":"10.1016\/j.jad.2024.08.077_bb0050","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2133.1986.tb05776.x","article-title":"Generalized pustular psoriasis precipitated by trazodone in the treatment of depression","volume":"115","author":"Barth","year":"1986","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172838","article-title":"Efficacy of infliximab in treatment-resistant depression: a systematic review and meta-analysis","volume":"188","author":"Bavaresco","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jad.2024.08.077_bb0060","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.psyneuen.2018.09.004","article-title":"Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression","volume":"98","author":"Bekhbat","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jad.2024.08.077_bb0065","doi-asserted-by":"crossref","DOI":"10.4081\/dr.2022.9476","article-title":"Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patient","volume":"14","author":"Bernardini","year":"2022","journal-title":"Dermatol. Reports"},{"key":"10.1016\/j.jad.2024.08.077_bb0070","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.3748\/wjg.v28.i34.5058","article-title":"Impact of adalimumab on disease burden in moderate-to-severe ulcerative colitis patients: the one-year, real-world UCanADA study","volume":"28","author":"Bessissow","year":"2022","journal-title":"WJG"},{"key":"10.1016\/j.jad.2024.08.077_bb0075","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.jaad.2012.10.009","article-title":"A prospective, interventional assessment of psoriasis quality of life using a nonskin-specific validated instrument that allows comparison with other major medical conditions","volume":"69","author":"Bhutani","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0080","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s40744-023-00533-5","article-title":"Response to treatment with intravenous Golimumab or infliximab in rheumatoid arthritis patients: PROMIS results from the real-world observational phase 4 AWARE study","volume":"10","author":"Bingham","year":"2023","journal-title":"Rheumatol Ther, \u65e0"},{"key":"10.1016\/j.jad.2024.08.077_bb0085","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/jamadermatol.2022.3917","article-title":"Apremilast in recalcitrant cutaneous dermatomyositis: a nonrandomized controlled trial","volume":"158","author":"Bitar","year":"2022","journal-title":"JAMA Dermatol, \u65e0"},{"key":"10.1016\/j.jad.2024.08.077_bb0090","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/10401230600948522","article-title":"Letter To The Editor: \u201cDepression and Psoriasis Comorbidity. Treatment with Paroxetine: Two Case Reports.\u201d","volume":"18","author":"Blay","year":"2006","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.08.077_bb0095","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/0128071-200809060-00012","article-title":"Improvement in psoriasis following treatment with gabapentin and Pregabalin","volume":"9","author":"Boyd","year":"2008","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0100","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12888-017-1411-2","article-title":"Antipsychotic-associated psoriatic rash \u2013 a case report","volume":"17","author":"Bujor","year":"2017","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2024.08.077_bb0105","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/cod.13875","article-title":"Patch test\u2013proven delayed-type hypersensitivity from naltrexone\/bupropion possibly eliciting psoriasis","volume":"85","author":"Caldas","year":"2021","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jad.2024.08.077_bb0110","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0033-3182(72)71404-8","article-title":"The relationship of Lithium carbonate to psoriasis","volume":"13","author":"Carter","year":"1972","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jad.2024.08.077_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/S0165-0327(99)00064-6","article-title":"A control study of the cutaneous side effects of chronic lithium therapyq","author":"Chan","year":"2000","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.08.077_bb0120","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41398-020-01095-8","article-title":"A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosis","volume":"10","author":"Chaudhry","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2024.08.077_bb0125","doi-asserted-by":"crossref","first-page":"350","DOI":"10.21037\/apm-20-2293","article-title":"The prevalence of bipolar disorder in autoimmune disease: a systematic review and meta-analysis. Ann","volume":"10","author":"Chen","year":"2021","journal-title":"Palliat. Med."},{"key":"10.1016\/j.jad.2024.08.077_bb0130","doi-asserted-by":"crossref","first-page":"811","DOI":"10.4103\/IJPSYM.IJPSYM_21_17","article-title":"Olanzapine-induced Psoriasis","volume":"39","author":"Chepure","year":"2017","journal-title":"Indian J. Psychol. Med."},{"key":"10.1016\/j.jad.2024.08.077_bb0135","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/MPG.0000000000000277","article-title":"Predictors of depression in youth with Crohn disease","volume":"58","author":"Clark","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jad.2024.08.077_bb0140","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1046\/j.1365-2133.2002.04679.x","article-title":"Generalized pustular and erythrodermic psoriasis associated with bupropion treatment","volume":"146","author":"Cox","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0145","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/s12891-016-1318-y","article-title":"The Scottish early rheumatoid arthritis (SERA) study: an inception cohort and biobank","volume":"17","author":"Dale","year":"2016","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.jad.2024.08.077_bb0150","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/j.1468-3083.2009.03321.x","article-title":"Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study: patient-reported outcomes in psoriasis patients treated with etanercept","volume":"23","author":"Daud\u00e9n","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jad.2024.08.077_bb0155","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1468-3083.2012.04690.x","article-title":"Therapeutic implications of adding the psychotropic drug escitalopram in the treatment of patients suffering from moderate-severe psoriasis and psychiatric comorbidity: a retrospective study: escitalopram and psoriasis","volume":"28","author":"D\u2019Erme","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jad.2024.08.077_bb0160","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3899\/jrheum.141313","article-title":"Evaluation of health outcomes with Etanercept treatment in patients with early nonradiographic axial Spondyloarthritis","volume":"42","author":"Dougados","year":"2015","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0165","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2024.08.077_bb0170","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/jid.2013.508","article-title":"The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis","volume":"134","author":"Dowlatshahi","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0175","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/ced.12351","article-title":"Suicide and depression in a patient with psoriasis receiving adalimumab: the role of the dermatologist","volume":"39","author":"Ellard","year":"2014","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0180","first-page":"262","article-title":"The effect of infliximab on depressive symptoms in patients with ankylosing spondylitis","volume":"40","author":"Ers\u00f6zl\u00fc-Bozk\u0131rl\u0131","year":"2015","journal-title":"Acta Reumatol. Port."},{"key":"10.1016\/j.jad.2024.08.077_bb0185","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00296-010-1616-x","article-title":"Infliximab, a TNF-alpha antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level","volume":"32","author":"Ertenli","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jad.2024.08.077_bb0190","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.crohns.2010.04.001","article-title":"Suicide attempt in ulcerative colitis patient after 4months of infliximab therapy \u2014 a case report","volume":"4","author":"Eshuis","year":"2010","journal-title":"Journal of Crohn\u2019s and Colitis"},{"key":"10.1016\/j.jad.2024.08.077_bb0195","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2340\/00015555-2702","article-title":"Antidepressants have anti-inflammatory effects that may be relevant to dermatology: a systematic review","volume":"97","author":"Eskeland","year":"2017","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.jad.2024.08.077_bb0200","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/00325481.2020.1712153","article-title":"Long-term safety and efficacy of secukinumab in patients with psoriasis and major psychiatric disorders: a case series","volume":"132","author":"Esposito","year":"2020","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.jad.2024.08.077_bb0205","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1176\/ajp.136.10.1326","article-title":"Lithium carbonate and psoriasis","volume":"136","author":"Evans","year":"1979","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.08.077_bb0210","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1365-2133.2008.08727.x","article-title":"Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis","volume":"159","author":"Feldman","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0215","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/09546634.2019.1708854","article-title":"Secukinumab rapidly improves EQ-5D health status in patients with psoriasis: pooled analysis from four phase 3 trials","volume":"32","author":"Feldman","year":"2021","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.jad.2024.08.077_bb0220","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/jdv.13891","article-title":"The prevalence of anxiety in patients with psoriasis: a systematic review of observational studies and clinical trials","volume":"31","author":"Fleming","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jad.2024.08.077_bb0225","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.18460","article-title":"Erythrodermic psoriasis exacerbated by bupropion","author":"Foss","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jad.2024.08.077_bb0230","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/j.1468-3083.2009.03216.x","article-title":"Moderate to severe psoriasis: from topical to biological treatment","volume":"23","author":"Gardinal","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jad.2024.08.077_bb0235","first-page":"38","article-title":"Lithium-induced linear psoriasis: a rare presentation","volume":"12","author":"Garg","year":"2019","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0240","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1524-4733.2007.00251.x","article-title":"Patient-reported outcomes and health-care resource utilization in patients with psoriasis treated with Etanercept: continuous versus interrupted treatment","volume":"11","author":"Gelfand","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.jad.2024.08.077_bb0245","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/j.1468-3083.2011.04308.x","article-title":"Self-reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens: self-reported health outcomes in psoriasis","volume":"26","author":"Gniadecki","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jad.2024.08.077_bb0250","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.intimp.2014.02.030","article-title":"Selective serotonin reuptake inhibitors as a novel class of immunosuppressants","volume":"20","author":"Gobin","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jad.2024.08.077_bb0255","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1684\/ejd.2010.1180","article-title":"Drug eruption and exacerbation of psoriasis related to bupropion","volume":"21","author":"G\u00f3mez-Fern\u00e1ndez","year":"2011","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0260","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1111\/jdv.15012","article-title":"Anxiety and depression in patients with moderate-to-severe psoriasis and comparison of change from baseline after treatment with guselkumab vs. adalimumab: results from the phase 3 VOYAGE 2 study","volume":"32","author":"Gordon","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jad.2024.08.077_bb0265","volume":"2","author":"Greb","year":"2016","journal-title":"Psoriasis. Nat Rev Dis Primers"},{"key":"10.1016\/j.jad.2024.08.077_bb0270","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000479163","article-title":"Impact of Ixekizumab treatment on depressive symptoms and systemic inflammation in patients with moderate-to-severe psoriasis: an integrated analysis of three phase 3 clinical studies","volume":"86","author":"Griffiths","year":"2017","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jad.2024.08.077_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/823469","article-title":"Psoriasiform drug eruption associated with sodium valproate","volume":"2013","author":"Gul Mert","year":"2013","journal-title":"Case Reports in Pediatrics"},{"key":"10.1016\/j.jad.2024.08.077_bb0280","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/12034754221088584","article-title":"Real-world moderate-to-severe hidradenitis Suppurativa: decrease in disease burden with adalimumab","volume":"26","author":"Gulliver","year":"2022","journal-title":"J. Cutan. Med. Surg."},{"key":"10.1016\/j.jad.2024.08.077_bb0285","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF02795684","article-title":"Development of a psoriasis-like syndrome following lithium therapy","volume":"14","author":"Hanada","year":"1987","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.jad.2024.08.077_bb0290","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0140-6736(05)63946-3","article-title":"Can lithium in spring water provoke psoriasis?","volume":"350","author":"Hanada","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2024.08.077_bb0295","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/2045125313477103","article-title":"Contribution of methotrexate in precipitation of manic episode in bipolar affective disorder explored: a case report","volume":"3","author":"Hariram","year":"2013","journal-title":"Therapeutic Advances in Psychopharmacology"},{"key":"10.1016\/j.jad.2024.08.077_bb0300","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.genhosppsych.2022.01.006","article-title":"Associations between psoriasis and mental illness: an update for clinicians","volume":"75","author":"Hedemann","year":"2022","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jad.2024.08.077_bb0305","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12888-019-2107-6","article-title":"First known case of catatonia due to cyclosporine A-related neurotoxicity in a pediatric patient with steroid-resistant nephrotic syndrome","volume":"19","author":"Heekin","year":"2019","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2024.08.077_bb0310","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s10067-013-2337-9","article-title":"The relationship between disease activity and depressivesymptoms severity and optimism\u2014results from the IMPROVED study","volume":"32","author":"Heimans","year":"2013","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0315","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/106002809202600215","article-title":"Fluoxetine-induced psoriasis","volume":"26","author":"Hemlock","year":"1992","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.jad.2024.08.077_bb0320","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1192\/S0007125000219193","article-title":"Lithium, psoriasis, abnormal glucose tolerance, and thyroid dysfunction","volume":"152","author":"Humphreys","year":"1988","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.08.077_bb0325","first-page":"113","article-title":"A rare case of suicidal ideation related to adalimumab use","volume":"10","author":"Jafri","year":"2018"},{"key":"10.1016\/j.jad.2024.08.077_bb0330","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/exd.14838","article-title":"Generalized pustular psoriasis caused by bupropion with rapid recurrence after self-rechallenge","volume":"32","author":"Jeng","year":"2023","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0335","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00004850-200507000-00008","article-title":"Etanercept, anticytokines and mania","volume":"20","author":"Kaufman","year":"2005","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.08.077_bb0340","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2008.102509","article-title":"Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial","volume":"69","author":"Kekow","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jad.2024.08.077_bb0345","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/09546634.2018.1466021","volume":"29","author":"Kim","year":"2018","journal-title":"Journal of Dermatological Treatment"},{"key":"10.1016\/j.jad.2024.08.077_bb0350","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2165\/11530640-000000000-00000","article-title":"Efficacy and safety of adalimumab among patients with moderate to severe psoriasis with co-morbidities: subanalysis of results from a randomized, double-blind, placebo-controlled, phase III trial","volume":"12","author":"Kimball","year":"2011","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0355","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.annder.2022.09.003","article-title":"Psoriasis exacerbation associated with bupropion-induced exanthema","volume":"150","author":"Kluger","year":"2023","journal-title":"Ann. Dermatol. Venereol."},{"key":"10.1016\/j.jad.2024.08.077_bb0360","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1684\/ejd.2016.2832","article-title":"Exacerbation of depression in a psoriatic arthritis patient possibly induced by secukinumab","volume":"26","author":"Komori","year":"2016","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0365","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1757-1626-3-69","article-title":"Administration of inositol to a patient with bipolar disorder and psoriasis: a case report","volume":"3","author":"Kontoangelos","year":"2010","journal-title":"Cases J."},{"key":"10.1016\/j.jad.2024.08.077_bb0370","doi-asserted-by":"crossref","DOI":"10.22365\/jpsych.2021.011","article-title":"Suicidal thoughts in a patient after administration of infliximab","author":"Kontoangelos","year":"2021","journal-title":"Psychiatriki"},{"key":"10.1016\/j.jad.2024.08.077_bb0375","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1365-2133.2007.08205.x","article-title":"Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks","volume":"157","author":"Krishnan","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0380","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jaad.2009.09.014","article-title":"Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: results from a randomized, double-blind, placebo-controlled phase III trial","volume":"63","author":"Langley","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0385","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bbi.2020.04.063","article-title":"Efficacy of adjunctive infliximab vs. placebo in the treatment of anhedonia in bipolar I\/II depression","volume":"88","author":"Lee","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2024.08.077_bb0390","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/09546634.2019.1592096","article-title":"The real world impact of adalimumab on quality of life and the physical and psychological effects of moderate-to-severe psoriasis: a UK prospective, multicenter, observational study","volume":"31","author":"Leman","year":"2020","journal-title":"Journal of Dermatological Treatment"},{"key":"10.1016\/j.jad.2024.08.077_bb0395","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jaad.2019.06.005","article-title":"Benzodiazepine receptor agonists and subsequent risk of psoriasis: a 5-year follow-up cohort study","volume":"81","author":"Li","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0400","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2024.08.077_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115078","article-title":"Epidemiology of mental health comorbidity in patients with psoriasis: an analysis of trends from 1986 to 2019","volume":"321","author":"Liu","year":"2023","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2024.08.077_bb0410","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1111\/j.1572-0241.2008.02175.x","article-title":"Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn\u2019s disease: patient-reported outcomes of the CHARM trial","volume":"103","author":"Loftus","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jad.2024.08.077_bb0415","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/ibd\/izac121","article-title":"Tofacitinib response in ulcerative colitis (TOUR): early response after initiation of Tofacitinib therapy in a real-world setting","volume":"29","author":"Long","year":"2023","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jad.2024.08.077_bb0420","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1001\/archderm.1978.01640240030009","article-title":"Generalized pustular psoriasis precipitated by lithium carbonate","volume":"114","author":"Lowe","year":"1978","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0425","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/RHU.0000000000000055","article-title":"Open-label observation of addition of Etanercept versus a conventional disease-modifying Antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region","volume":"20","author":"Machado","year":"2014","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020669","article-title":"The brain-skin Axis in psoriasis-psychological, psychiatric, hormonal, and dermatological aspects","volume":"23","author":"Marek-Jozefowicz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jad.2024.08.077_bb0435","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1111\/jdv.13876","article-title":"Erythrodermic psoriasis induced by bupropion","volume":"31","author":"Matos-Pires","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jad.2024.08.077_bb0440","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/annrheumdis-2015-207768","article-title":"A patient-initiated DMARD self-monitoring service for people with rheumatoid or psoriatic arthritis on methotrexate: a randomised controlled trial","volume":"75","author":"McBain","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jad.2024.08.077_bb0445","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jamapsychiatry.2019.0779","article-title":"Efficacy of adjunctive infliximab vs placebo in the treatment of adults with bipolar I\/II depression: a randomized clinical trial","volume":"76","author":"McIntyre","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2024.08.077_bb0450","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbi.2013.04.004","article-title":"Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression","volume":"31","author":"Mehta","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2024.08.077_bb0455","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jaad.2009.07.022","article-title":"The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial","volume":"62","author":"Menter","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0460","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5152\/eurjrheumatol.2014.140074","article-title":"Combined infliximab and methotrexate treatment improves the depressive state in rheumatoid arthritis patients more effectively than methotrexate alone","volume":"1","author":"Miwa","year":"2014","journal-title":"Eur J Rheumatol"},{"key":"10.1016\/j.jad.2024.08.077_bb0465","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.2169\/internalmedicine.55.6872","article-title":"Comparative study of infliximab therapy and methotrexate monotherapy to improve the clinical effect in rheumatoid arthritis patients","volume":"55","author":"Miwa","year":"2016","journal-title":"Intern. Med."},{"key":"10.1016\/j.jad.2024.08.077_bb0470","first-page":"835","article-title":"Treatment of atopic dermatitis and psoriasis vulgaris with bupropion-SR: a pilot study","volume":"64","author":"Modell","year":"2002","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.jad.2024.08.077_bb0475","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/YIC.0000000000000399","article-title":"Risperidone combination therapy with adalimumab for treatment of chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial","volume":"37","author":"Motamed","year":"2022","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.08.077_bb0480","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1590\/abd1806-4841.20153858","article-title":"A case of generalized ostraceous psoriasis mimicking dermatitis neglecta","volume":"90","author":"Nascimento","year":"2015","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0485","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s13555-023-00909-z","article-title":"Effectiveness of Long-term treatment with Brodalumab on anxiety or depressive symptoms in Japanese patients with psoriasis: the ProLOGUE study","volume":"13","author":"Ohata","year":"2023","journal-title":"Dermatology Ther"},{"key":"10.1016\/j.jad.2024.08.077_bb0490","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1346-8138.2010.01041.x","article-title":"Low-dose, short-term ciclosporin (Neoral\u00ae) therapy is effective in improving patients\u2019 quality of life as assessed by Skindex-16 and GHQ-28 in mild to severe psoriasis patients: QOL and ciclosporin therapy in psoriasis","volume":"38","author":"Okubo","year":"2011","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0495","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s40271-022-00588-6","article-title":"Meaningful improvement in general health outcomes with Guselkumab treatment for psoriatic arthritis: patient-reported outcomes measurement information System-29 results from a phase 3 study","volume":"15","author":"Orbai","year":"2022","journal-title":"Patient"},{"key":"10.1016\/j.jad.2024.08.077_bb0500","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1176\/appi.ajp.159.12.2113","article-title":"Paroxetine-associated psoriasis","volume":"159","author":"Osborne","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.08.077_bb0505","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ueg2.12384","article-title":"Ustekinumab improves health-related quality of life in patients with moderate-to-severe Crohn\u2019s disease: results up to week 104 of the STARDUST trial","volume":"11","author":"Pan\u00e9s","year":"2023","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.jad.2024.08.077_bb0510","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/jdv.12138","article-title":"Disease characteristics in patients with and without psoriatic arthritis treated with etanercept","volume":"28","author":"Papp","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jad.2024.08.077_bb0515","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/bjd.17004","article-title":"Psychiatric morbidity and suicidal behaviour in psoriasis: a primary care cohort study","volume":"180","author":"Parisi","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0520","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2024.08.077_bb0525","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11255-013-0447-6","article-title":"IgG4-related tubulointerstitial nephritis presenting with psychiatric manifestations and skin lesions","volume":"46","author":"Ramachandran","year":"2014","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.jad.2024.08.077_bb0530","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s40257-020-00555-7","article-title":"Maintenance of response through up to 4 years of continuous Guselkumab treatment of psoriasis in the VOYAGE 2 phase 3 study","volume":"21","author":"Reich","year":"2020","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0535","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/bjd\/ljac086","article-title":"Exploring disease comorbidities and temporal disease progression of psoriasis: an observational, retrospective, multi-database, cohort study","volume":"188","author":"Rosen\u00f8","year":"2023","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0540","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0190-9622(08)80533-6","article-title":"Lithium-induced psoriasis of the fingernails","volume":"26","author":"Rudolph","year":"1992","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0545","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1365-2133.2002.04806.x","article-title":"Topiramate in the treatment of psoriasis: a pilot study","volume":"147","author":"Ryback","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0550","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1346-8138.1989.tb01220.x","article-title":"Exacerbation of psoriasis during Lithium treatment","volume":"16","author":"Sasaki","year":"1989","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0555","doi-asserted-by":"crossref","DOI":"10.5070\/D3223030360","article-title":"Reduction in pain scores and improvement in depressive symptoms in patients with hidradenitis suppurativa treated with adalimumab in a phase 2, randomized, placebo-controlled trial","volume":"22","author":"Scheinfeld","year":"2016","journal-title":"Dermatol. Online J."},{"key":"10.1016\/j.jad.2024.08.077_bb0560","first-page":"288","article-title":"The TNF-alpha inhibitor etanercept as monotherapy in treatment-resistant depression - report of two cases","volume":"26","author":"Schmidt","year":"2014","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.jad.2024.08.077_bb0565","doi-asserted-by":"crossref","DOI":"10.1097\/pq9.0000000000000229","article-title":"Infliximab-induced depression and suicidal behavior in adolescent with Crohn\u2019s disease: case report and review of literature","volume":"4","author":"Shayowitz","year":"2019","journal-title":"Pediatric Quality & Safety"},{"key":"10.1016\/j.jad.2024.08.077_bb0570","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.jemermed.2016.11.034","article-title":"Acute generalized Erythrodermic pustular psoriasis associated with bupropion\/naltrexone (Contrave \u00ae)","volume":"52","author":"Singh","year":"2017","journal-title":"J. Emerg. Med."},{"key":"10.1016\/j.jad.2024.08.077_bb0575","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3109\/00048678709158929","article-title":"Psoriatic arthritis during Lithium therapy","volume":"21","author":"Skerritt","year":"1987","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.08.077_bb0580","doi-asserted-by":"crossref","unstructured":"Skoven, I., Thormann, J., 1979 Lithium compound treatment and psoriasis. https:\/\/doi.org\/10.1001\/archderm.1979.04010100005003.","DOI":"10.1001\/archderm.1979.04010100005003"},{"key":"10.1016\/j.jad.2024.08.077_bb0585","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.jad.2024.08.077_bb0590","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2024.08.077_bb0595","article-title":"An uncommon side effect of bupropion: a case of acute generalized Exanthematous Pustulosis","volume":"2015","author":"Tak","year":"2015","journal-title":"Case Rep. Dermatol. Med."},{"key":"10.1016\/j.jad.2024.08.077_bb0600","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0605","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3712","article-title":"Secukinumab improves patient perception of anxiety and depression in patients with moderate to severe psoriasis: a post hoc analysis of the SUPREME study","volume":"101","author":"Talamonti","year":"2021","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.jad.2024.08.077_bb0610","doi-asserted-by":"crossref","first-page":"446.e9","DOI":"10.1016\/j.genhosppsych.2009.08.008","article-title":"Onset of psoriasis during therapy with fluoxetine","volume":"32","author":"Tan Pei Lin","year":"2010","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jad.2024.08.077_bb0615","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00520-008-0429-x","article-title":"Fatigue in patients with advanced cancer: a pilot study of an intervention with infliximab","volume":"16","author":"Tookman","year":"2008","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.jad.2024.08.077_bb0620","first-page":"367","author":"Tyring","year":"2006","journal-title":"Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial"},{"key":"10.1016\/j.jad.2024.08.077_bb0625","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.psychres.2017.11.021","article-title":"Patients with schizophrenia have a higher risk of psoriasis: a systematic review and meta-analysis","volume":"259","author":"Ungprasert","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2024.08.077_bb0630","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/jpgm.JPGM_253_18","article-title":"Patients with psoriasis have a higher risk of schizophrenia: a systematic review and meta-analysis of observational studies","volume":"65","author":"Ungprasert","year":"2019","journal-title":"J. Postgrad. Med."},{"key":"10.1016\/j.jad.2024.08.077_bb0635","doi-asserted-by":"crossref","DOI":"10.1136\/gpsych-2019-100181","article-title":"Comorbid psoriasis-bipolar disorder successfully treated with apremilast: much more than a mere coincidence?","volume":"33","author":"Uvais","year":"2020","journal-title":"Gen Psych"},{"key":"10.1016\/j.jad.2024.08.077_bb0640","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s13075-020-02305-w","article-title":"Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)","volume":"22","author":"Webers","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jad.2024.08.077_bb0645","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0190-9622(82)70147-1","article-title":"Palmoplantar pustular psoriasis provoked by lithium therapy","volume":"7","author":"White","year":"1982","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0650","doi-asserted-by":"crossref","unstructured":"Yang, Y., Lyu, X., 2023. Lithium-associated generalized Ostraceous psoriasis treated with adalimumab: a case report. CCID Volume 16, 947\u2013950. https:\/\/doi.org\/10.2147\/CCID.S408245.","DOI":"10.2147\/CCID.S408245"},{"key":"10.1016\/j.jad.2024.08.077_bb0655","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.annder.2019.03.002","article-title":"Etanercept reduces anxiety and depression in psoriasis patients, and sustained depression correlates with reduced therapeutic response to etanercept","volume":"146","author":"Yang","year":"2019","journal-title":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie, \u65e0"},{"key":"10.1016\/j.jad.2024.08.077_bb0660","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1440-0960.2008.00487.x","article-title":"Infliximab rescue of efalizumab withdrawal flare and psoriasis-precipitated depression","volume":"49","author":"Yip","year":"2008","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.jad.2024.08.077_bb0665","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/jdv.14303","article-title":"Risk of developing psoriasis in patients with schizophrenia: a nationwide retrospective cohort study","volume":"31","author":"Yu","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jad.2024.08.077_bb0670","first-page":"879","article-title":"Improvement of psychological status after infliximab treatment in patients with newly diagnosed Crohn’s disease","volume":"12","author":"Zhang","year":"2018"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724012904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724012904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T21:35:35Z","timestamp":1725658535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032724012904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":134,"alternative-id":["S0165032724012904"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2024.08.077","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of drugs for psoriasis patients with mental disorders: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2024.08.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}